Target intelligence / Profile preview

Alpha-1,4-glucan (Dietary starch)

Molecular classification
Carbohydrate, Polysaccharide, Alpha-glucan
01

Overview

Dietary starches and other polysaccharides containing α-1,4-glycosidic linkages are complex carbohydrates that serve as the primary energy storage molecules in plants and a major caloric source for humans (PubChem, CID 24836924). These molecules, primarily amylose and amylopectin, consist of glucose units joined by α-1,4-glycosidic bonds, which are hydrolyzed by salivary and pancreatic alpha-amylase and intestinal alpha-glucosidase enzymes into absorbable monosaccharides (StatPearls, Alpha-Glucosidase Inhibitors). In clinical medicine, these polysaccharides are significant because their digestion rate directly influences postprandial glycemic levels, making them central to the management of Type 2 diabetes and obesity (NIH, PubMed PMID 11730160). While not a protein target themselves, they are the substrates for key therapeutic targets; drugs like acarbose and miglitol competitively inhibit the enzymes that break these linkages to slow glucose absorption (DrugBank, DB00284). This mechanism helps prevent rapid spikes in blood glucose following carbohydrate ingestion, thereby improving long-term glycemic control as measured by HbA1c.

Other names
StarchAmyloseAmylopectinPolysaccharideAlpha-1,4-linked glucose polymer
02

Mechanism of action

Competitive inhibition of the enzymatic hydrolysis of α-1,4-glycosidic linkages by alpha-glucosidase and alpha-amylase enzymes (StatPearls).

03

Biological functions

Energy storageGlucose homeostasisDietary caloric source
04

Disease associations

Type 2 diabetes mellitusObesityPostprandial hyperglycemia
05

Safety considerations

Gastrointestinal side effects (flatulence, diarrhea, abdominal pain) (PubMed PMID 10429876)Malabsorption of complex carbohydratesPotential for hypoglycemia when used with other antidiabetic agents
06

Interacting drugs

Acarbose

2 more in the full profile.

07

Biomarkers

Postprandial blood glucoseHemoglobin A1c (HbA1c)1,5-Anhydroglucitol

Beyond the preview

Go deeper on Alpha-1,4-glucan (Dietary starch).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1,4-glucan (Dietary starch).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call